Back to search
Stage III Lung Non-Small Cell Cancer AJCC v7
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stage III Lung Non-Small Cell Cancer AJCC v7 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Stage III Lung Non-Small Cell Cancer AJCC v7 trials you may qualify forThe purpose of this study is to test whether or not number of circulating cancer cells detected in the blood can be decreased the by combining the standard trea…
A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Canc…
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage I…
This umbrella trial directed by next generation sequencing (NGS) includes patients with treatment-naive unresectable stage III non-small-cell lung cancer (NSCLC…
The purpose of this study is to studying neoadjuvant IBI308, bevacizumab, plus pemetrexed and carboplatin followed by surgery to see how well it works in treati…
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by…
This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomar…
This is an open-label, multi-center, randomized, phase III study. It is aimed to firstly evaluate the effectiveness and safety of almonertinib induction therapy…